LANZHOU -- A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which is expected to optimize cancer treatment strategies and promote ...

Researchers have developed innovative methods to control the ionization of atoms and molecules using specially structured light beams, challenging traditional limits. This breakthrough could lead to ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking ...

Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study reports a breakthrough imaging technique that allows direct and highly ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...

Gold nanoparticles (AuNPs) are tiny gold particles of 1–100 nanometers and have unique chemical and biological properties. Due to their potential to ...